TVT INFRACON LLP's most recent trade in SMS Pharmaceuticals Ltd. was a Acquisition of 80,000 Equity Shares done at an average price of Rs. 183.5 . Disclosure was reported to the exchange on March 29, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
TVT INFRACON LLP's has made SAST transactions in SMS Pharmaceuticals Ltd. recently where a Acquisition of 80,000 shares done . Disclosure was reported to the exchange on March 29, 2024.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SMS Pharmaceuticals | TVT INFRACON LLP | Promoter Group | Acquisition | 29 Mar 2024 | 80,000 | 100,000 (0.12%) | 0.09% | 183.5 | 14,683,083 | 27 Mar 2024 27 Mar 2024 |
Insider Trading | Equity Shares | Market Purchase |
SMS Pharmaceuticals | TVT Infracon LLP | Promoter | Acquisition | 10 Apr 2024 | 80,000 | 100,000 (0.12%) | 0.10% | - | 27 Mar 2024 28 Mar 2024 |
SAST (29(2)) | - | Market | |
SMS Pharmaceuticals | TVT INFRACON LLP | Promoter Group | Acquisition | 21 Jun 2023 | 20,000 | 20,000 (0.02%) | 0.02% | 93.8 | 1,875,398 | 19 Jun 2023 20 Jun 2023 |
Insider Trading | Equity Shares | Market Purchase |
SMS Pharmaceuticals | TVT Infracon LLP | Promoter | Acquisition | 11 Jul 2023 | 20,000 | 20,000 (0.02%) | 0.02% | - | 19 Jun 2023 20 Jun 2023 |
SAST (29(2)) | - | Market |